CYRX - Cryoport Inc. (CYRX) Q4 2023 Earnings Call Transcript
2024-03-12 20:48:03 ET
Cryoport, Inc. (CYRX)
Q4 2023 Earnings Call Transcript
March 12, 2024, 05:00 PM ET
Company Participants
Todd Fromer - IR, KCSA Strategic Communications
Jerrell Shelton - CEO
Mark Sawicki - Chief Scientific Officer
Robert Stefanovich - CFO
Thomas Heinzen - VP of Corporate Development and IR
Conference Call Participants
Puneet Souda - Leerink Partners
David Saxon - Needham
Tejas Savant - Morgan Stanley
John Sourbeer - UBS
David Larsen - BTIG
Yuan Zhi - B. Riley Securities
Paul Knight - KeyBanc
Presentation
Operator
Good afternoon and welcome to Cryoport's Fourth Quarter and Full Year 2023 Conference Call. All participants will start in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the call over to your host, Todd Fromer from KCSA Strategic Communications. Please go ahead.
Todd Fromer
Thank you, operator. Before we begin today, I would like to remind everyone that this conference call contains certain forward-looking statements. All statements that address our operating performance, events, or developments that we expect or anticipate occurring in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and not on information currently available to our management team. Our management team believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events, and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include but are not limited to those described in Item 1A, risk factors, and elsewhere in our annual report on Form 10-K filed with the Securities and Exchange Commission and those described from time to time in the other reports which we file with the Securities and Exchange Commission.
With nothing further, it is now my pleasure to turn the call over to Mr. Jerrell Shelton, Chief Executive Officer of Cryoport. Jerry, the floor is yours.
Jerrell Shelton
Thank you, Todd. Good afternoon, ladies and gentlemen. Thank you for joining our earnings call today. With us this afternoon is Chief Financial Officer, Robert Stefanovich; our Chief Scientific Officer, Dr. Mark Sawicki; and our Vice President of Corporate Development and Investor Relations, Thomas Heinzen....
Cryoport, Inc. (CYRX) Q4 2023 Earnings Call Transcript